Close

Hologic (HOLX) Announces FDA Clearance, Availability of Affirm Prone Biopsy System

April 21, 2016 8:04 AM EDT Send to a Friend
Hologic, Inc. (Nasdaq: HOLX) today announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login